Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence

TA Ollila, AJ Olszewski - Current treatment options in oncology, 2018 - Springer
Opinion statement Diffuse large B cell lymphoma (DLBCL) arises from extranodal organs in
about 30% of cases. Its prognosis and risk of recurrence in the central nervous system …

Frontline treatment of diffuse large B‐cell lymphoma: Beyond R‐CHOP

P Mondello, M Mian - Hematological oncology, 2019 - Wiley Online Library
Although the majority of patients with diffuse large B‐cell lymphoma (DLBCL) can be cured
with the standard immunochemotherapy R‐CHOP, one‐third of them relapses with a dismal …

Revised adult T-cell leukemia-lymphoma international consensus meeting report

LB Cook, S Fuji, O Hermine, A Bazarbachi… - Journal of Clinical …, 2019 - ascopubs.org
Purpose Adult T-cell leukemia-lymphoma (ATL) is a distinct mature T-cell malignancy
caused by chronic infection with human T-lymphotropic virus type 1 with diverse clinical …

ACKR3 promotes CXCL12/CXCR4-mediated cell-to-cell-induced lymphoma migration through LTB4 production

P Antonello, DU Pizzagalli, M Foglierini… - Frontiers in …, 2023 - frontiersin.org
Chemotaxis is an essential physiological process, often harnessed by tumors for metastasis.
CXCR4, its ligand CXCL12 and the atypical receptor ACKR3 are overexpressed in many …

Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapy

Z Yao, L Deng, ZY Xu-Monette, GC Manyam, P Jain… - Leukemia, 2018 - nature.com
In diffuse large B-cell lymphoma (DLBCL), the clinical and biological significance of
concordant and discordant bone marrow (BM) involvement have not been well investigated …

[HTML][HTML] ACKR3 expression on diffuse large B cell lymphoma is required for tumor spreading and tissue infiltration

V Puddinu, S Casella, E Radice, S Thelen… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Diffuse large B cell lymphoma (DLBCL) is the most frequent lymphoma accounting for more
than the 30% of the cases. Involvement of extranodal sites, such as bone marrow and …

Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis

K Lee, DH Yoon, JY Hong, S Kim, K Lee… - International Journal of …, 2019 - Springer
We evaluated the efficacy of systemic high-dose methotrexate (HD-MTX) for CNS
prophylaxis in a prospectively recruited cohort of DLBCL patients at high risk of CNS …

[Retracted] Mechanism of LncHOTAIR Regulating Proliferation, Apoptosis, and Autophagy of Lymphoma Cells through hsa‐miR‐6511b‐5p/ATG7 Axis

F Gui, X Yu, Y Wu, C Wu… - … Based Complementary and …, 2022 - Wiley Online Library
Objective. To explore the role of LncHOTAIR in apoptosis and autophagy in lymphoma.
Methods. The interaction between LncHOTAIR and miR‐6511b‐5p, as well as between miR …

Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma

BJG Chua, CE Low, CE Yau, YH Tan, J Chiang… - … Hematology & Oncology, 2024 - Springer
The use of central nervous system (CNS) prophylaxis for patients with diffuse large B-cell
lymphoma (DLBCL) remains controversial. Although uncommon, CNS relapses are …

Cancer seeding risk from an epidural blood patch in patients with leukemia or lymphoma

CJ Demaree, JM Soliz, R Gebhardt - Pain Medicine, 2017 - academic.oup.com
Introduction. Lumber punctures are a common procedure in patients with cancer. However,
a potential complication of a lumbar puncture is a postdural puncture headache. The risk of …